RVPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31

RETRACTABLE TECHNOLOGIES INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026

$0.58+0.00 (+0.33%)

Close on Oct 19, 2026

Market cap: $17.30M
P/E (TTM): –
Dividend yield: –

RETRACTABLE TECHNOLOGIES INC income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31	FY 2014 2014-12-31	FY 2013 2013-12-31	FY 2012 2012-12-31	FY 2011 2011-12-31	FY 2010 2010-12-31	FY 2009 2009-12-31
Revenue	38	33	44	95	188	82	42	33	34	30	30	35	31	34	32	36	39
Cost of Revenue	38	34	34	67	93	45	28	23	25	19	19	22	20	22	21	24	25
Gross Profit	0.05	-1.03	9.11	28	95	37	14	10	9.97	10	11	12	10	11	11	13	14
Research & Development	0.68	0.67	0.58	0.53	0.90	0.57	0.52	0.62	0.74	0.57	0.61	0.62	0.84	0.87	0.82	0.89	1.03
Selling, General & Admin	20	19	20	29	22	12	11	11	13	13	13	14	15	14	14	18	23
Selling & Marketing	6.82	5.85	5.71	4.54	4.48	4.06	4.22	4.40	4.66	4.03	3.84	3.97	4.41	4.22	3.44	3.67	4.37
General & Administrative	13	14	14	24	17	8.30	6.43	6.79	8.35	8.80	9.33	9.60	11	10	11	14	19
Operating Expenses	21	20	21	29	23	13	11	12	14	14	14	14	16	15	15	19	27
Operating Income	-21	-21	-11	-0.85	73	24	2.97	-1.33	-3.78	-3.51	-3.21	-2.16	-5.93	-3.94	-4.09	-6.66	-13
Interest Expense	0.09	0.12	0.15	0.17	0.23	0.26	0.17	0.18	0.21	0.21	0.22	0.22	0.23	0.23	0.24	0.30	0.02
Interest & Investment Income	–	–	–	–	–	2.26	0.35	0.15	0.07	0.03	0.02	0.03	0.04	0.05	0.06	0.03	0.06
Asset Impairment Charges	–	–	–	–	–	–	–	–	–	0.46	–	–	–	–	–	0.37	2.59
Gain (Loss) on Sale of Assets	–	–	–	–	–	-0.03	–	–	–	–	–	–	0.00	–	–	–	–
Legal Settlements	1.90	–	–	–	–	–	–	–	–	–	7.72	–	–	–	5.70	9.16	–
Pretax Income	-12	-3.52	-8.92	5.16	75	26	3.16	-1.35	-3.92	-3.69	4.32	-2.35	-6.12	-4.12	1.43	2.22	-13
Income Tax Expense	0.29	8.37	-1.91	0.08	19	1.85	0.01	-0.01	-0.19	0.00	0.01	0.01	0.09	0.01	0.01	-0.18	-3.84
Net Income incl. Noncontrolling Interests	-13	-12	-7.01	5.08	56	24	3.15	-1.34	-3.74	-3.69	4.31	–	–	–	–	–	–
Net Income	-13	-12	-7.01	5.08	56	24	3.15	-1.34	-3.74	-3.69	4.31	-2.35	-6.21	-4.13	1.42	2.40	-9.42
Preferred Dividends	0.23	0.23	0.23	0.23	0.24	0.57	0.70	0.70	0.70	0.70	0.71	0.92	0.92	0.92	0.96	1.37	1.37
Net Income to Common	-13	-12	-7.24	4.85	56	27	2.45	-2.04	-4.44	-4.40	5.91	-3.27	-7.13	-5.05	0.45	1.03	-11
EPS (Basic)(per share)	-0.43	-0.40	-0.24	0.15	1.65	0.80	0.07	-0.06	-0.14	-0.15	0.21	-0.12	-0.26	-0.19	0.02	0.04	-0.45
EPS (Diluted)(per share)	-0.43	-0.40	-0.24	0.15	1.63	0.80	0.07	-0.06	-0.14	-0.15	0.20	-0.12	-0.26	-0.19	0.02	0.04	-0.45
Shares Outstanding (Basic, Weighted)(shares)	30	30	30	33	34	33	33	33	32	29	28	27	27	26	24	24	24
Shares Outstanding (Diluted, Weighted)(shares)	30	30	30	33	34	33	33	33	32	29	29	27	27	26	26	26	24
EBITDA	-13	-14	-3.96	3.75	74	25	3.82	-0.44	-2.94	-2.63	-2.35	-1.08	-4.65	-2.60	-2.78	-5.15	-12

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: -1.4%
Operating margin: -66.9%
Net margin: -9.9%
Return on equity, FY2025: -15.6%

Financial strength

Current ratio: 4.93
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 19.8%

Valuation

P/E ratio: –
Price to sales: 0.51
Price to book: 0.24
Dividend yield: –